AnaptysBio, Inc ANAB

Xclusive-Trading Premium

Hopefully you find the chart helpful in terms of Supports & Resistance etc. we refrain from adding commentary on the chart as that is reserved for our members and we are very conscious of not giving financial or trading advice. Thank you for taking time to consult our chart and we would really appreciate a like, follow or comment.

dread003111

anab

RocketTickers

ANAB: AnaptysBio, Inc. 2021-04-22 16:12:09 FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer

Westful1991 Pro

www.tradingview.com Market maker set this one a little too low. Gap down on news catalyst. Really strong volume. Expect previous support to become new resistance.

chasethatmoney Pro+

Possible Short setting up with a hanging man candle on the 1 day chart. We are almost at the top of the channel so a open under the hanging mans real body would be a good place to open a short position with a stop loss maybe just above the hanging mans upper wick i would also wait for the 1st 30 minutes of trading to conclude before possibly trading this as to...

Bullishcharts Premium

Major trendline break today so lets see can we get continuation in the days to come. Like any trend break, back-tests are likely and bullish. Alert set at $24.50 for potential entry dependent on volume and market conditions. $25.79 target no 1 Indicators in Bullish reversal and Mondays volume very interesting.

Bullishcharts Premium

2 failed attempts to breakout last week but it did back-test the 2 year downtrend and it held as support. Alert set for break above $24.70 for potential day trade, depending on volume. Gap to $36.00 offers a 45% upside gain.

TizyCharts Pro

If count is confirmed🤩 we are going to start a wave 5 and close this impulse. We shouldn't go below $18 or the count may be invalidated 🧐🧐. Let's read the chart and don't anticipate the movement. Trade Smart ! 💡💡

dread003111

should go tomorrow.

TizyCharts Pro

The price is consolidating the previous move, indicators are turning up and price is following the MA15. Looks good !

Bullishcharts Premium

Nice spike in the afterhours session, lets hope we can get some continuation tomorrow. Target $29.00 to Fib Golden Pocket Also a very large gap to fill at $35.00 AnaptysBio gets orphan drug designation of imsidolimab for pustular psoriasis PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.

Alexey_Malorodov

Hey, traders! They've accumulated a good position in the hallway. Long is above the level.

InvestUpProfitCapital

AnaptysBio #ANAB can shoot long position target 30$ EPS Q/Q 63.00%

Alexey_Malorodov

NASDAQ:ANAB Hey, traders! Having overcome the historical level from 07.06.2017, formed by the paranormal bar, the instrument has faced the forces of the short player, who has placed a limit order at the level of 18.70. It happened on 04.03.2020, when the income reports were released. Naturally, it was not possible to take this hurdle "from the run": we came up...

RCB1229

Beat up, but has reacted "well" after the massive drop. 20% in a couple weeks time. No stop currently, but will begin using them soon. I think the risk/reward is in the favor of going long for a company that is reasonably sized and could be a potential buyout target (wishful thinking)... **I am long - happy trading

RocketTickers

ANAB: AnaptysBio, Inc. 2018-09-24 06:30:00 AnaptysBio Reports Positive Topline Data from Phase 2a Proof-of-Concept Clinical Trial of Etokimab in Severe Eosinophilic Asthma

09:53

themdtrader

Sorry for the stuffy nose! Nonetheless, here I talk about qualities of a trade that help determine it as a winner. This is just a short version of what to look for, just to give some of the things to consider in the process. As a general statement, there are 2 things that make up a stock: technical factors (price behavior) & fundamental factors (financial...

simplenothing Pro+

Looking to profit from high IV on September puts. This is probably a risky trade, but has high reward potential. I got a .20 credit on entering it today. Details on chart.